June 18, 2020: "The U.S. Food and Drug Administration approved Crysvita (burosumab-twza) injection to treat patients age two and older with tumor-induced osteomalacia (TIO),...
June 18, 2020: "The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
The FDA...
June 18, 2020: "Pfizer Inc. and Sangamo Therapeutics, Inc. announced updated follow-up data from the Phase 1/2 study of giroctocogene fitelparvovec (SB-525,...
 June 10, 2020: "AbbVie, a research-based global biopharmaceutical company announced new data from a Phase 2a study of ABBV-3373, an investigational anti-tumor necrosis factor...
 June 10, 2020: "AbbVie and Genmab A/S announced that AbbVie and Genmab have signed a broad collaboration agreement to jointly develop and commercialize...
June 08, 2020: "A study on children suffering from severe inflammatory symptoms shows the condition is new and distinct from Kawasaki disease.
A study led...
June 08, 2020: "Soleno Therapeutics announced top-line results from the Company’s Phase III trial, DESTINY PWS (C601), evaluating once-daily Diazoxide Choline Controlled-Release (DCCR) tablets...
June 09, 2020: "The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
On June...
June 08, 2020:Â "Oxford Biomedica plc, a leading gene and cell therapy group, announced that it has signed a Collaboration Agreement with the Vaccines Manufacturing...
June 08, 2020: "The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
On June...
June 8, 2020: "Sanofi will host a virtual scientific session to present data from the Phase 3 COMET trial of investigational enzyme replacement therapy...